Antibody stimulates natural repair of MS damage

Low doses of a human antibody in mice were effective in repairing damaged myelin, a protective shield for nerves that is destroyed by multiple sclerosis. Scientists at the Mayo Clinic engineered an antibody--rHIgM22--so that it would bind to myelin and brain and spinal cord cells. That antibody triggered remyelination, restoring the protective sheath. This is the first known therapy that acts within the central nervous system. In addition, the scientists said that even at a very high dose, there were no recorded side effects from the treatment.

- here's the report from the Washington Post

Related Article:
Natural protein used to combat multiple sclerosis. Report

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.